✦ LIBER ✦

Carboplatin and etoposide in advanced lung cancer: — a phase I study

✍ Scribed by K. Liippo; V. Nikkanen; E. Heinonen

Publisher: Springer
Year: 1990
Tongue: English
Weight: 519 KB
Volume: 27
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685718

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of carboplatin and oral

Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer

✍ Giuseppe Frasci; Giovanni Persico; Giuseppe Perillo; Giuseppe Comella; Pasquale 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

Background. A combination of carboplatin (CBDCA) and oral etoposide is better tolerated than, and as effective as, more aggressive chemotherapy regimens in patients with advanced nonsmall cell lung cancer (NSCLC). A Phase 1/11 study was conducted to determine whether the addition of the granulocyte-

Carboplatin and etoposide in advanced co

Carboplatin and etoposide in advanced colorectal carcinoma. A phase II study

✍ Branislav Jeremic; Ljubisa Acimovic; Ljiljana Mijatovic 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 2 views

## Background: For advanced colorectal carcinoma, 5-fluorouracil (5-fu)-leucovorin is the best therapy available. to improve results, a variety of drugs were added, including cisplatin (cddp), sometimes with controversial results. the combination of cddp and etoposide (vp-16) has shown synergistic

Carboplatin and vinblastine in advanced

Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study

✍ D. Doll; M. Goutsou; S. Graziano; J. Ellerton; J. Bitran; C. Modeas; J. Herndon; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 426 KB

Phase I misonidazole in advanced lung ca

Phase I misonidazole in advanced lung cancer

✍ Cristopher H. Fryer 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Etoposide in patients with previously un

Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study

✍ N. Niederle; J. Ostermann; W. Achterrath; L. Lenaz; C. G. Schmidt 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 456 KB

Phase II trial of carboplatin and etopos

Phase II trial of carboplatin and etoposide in metastatic breast cancer

✍ John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg